UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 90 filers reported holding UTAH MED PRODS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,223,637 | +139.0% | 33,283 | +154.3% | 0.01% | +166.7% |
Q1 2024 | $930,545 | +91.6% | 13,086 | +127.0% | 0.00% | +50.0% |
Q4 2023 | $485,613 | -2.1% | 5,766 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $495,876 | -6.9% | 5,766 | +0.9% | 0.00% | 0.0% |
Q2 2023 | $532,452 | +6.8% | 5,713 | +8.6% | 0.00% | 0.0% |
Q1 2023 | $498,680 | -10.4% | 5,262 | -5.0% | 0.00% | -33.3% |
Q4 2022 | $556,635 | +17.9% | 5,537 | 0.0% | 0.00% | +50.0% |
Q3 2022 | $472,000 | -0.8% | 5,537 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $476,000 | +43.8% | 5,537 | +50.1% | 0.00% | +100.0% |
Q1 2022 | $331,000 | -10.3% | 3,688 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $369,000 | +7.9% | 3,688 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $342,000 | -2.8% | 3,688 | -10.9% | 0.00% | 0.0% |
Q2 2021 | $352,000 | -1.7% | 4,138 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $358,000 | +44.4% | 4,138 | +40.4% | 0.00% | +100.0% |
Q4 2020 | $248,000 | +5.5% | 2,947 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $235,000 | -0.4% | 2,947 | +10.6% | 0.00% | 0.0% |
Q2 2020 | $236,000 | – | 2,665 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Ten Partners LP | 271,139 | $16,282,000 | 5.30% |
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 188,732 | $11,333,000 | 2.93% |
Opus Capital Group, LLC | 36,877 | $2,214,000 | 0.32% |
Clean Yield Group | 8,581 | $515,000 | 0.23% |
Ativo Capital Management LLC | 7,372 | $443,000 | 0.18% |
Ancora Advisors LLC | 22,009 | $1,322,000 | 0.16% |
Penobscot Investment Management Company, Inc. | 6,000 | $360,000 | 0.11% |
Wallace Capital Management Inc. | 9,010 | $541,000 | 0.10% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $2,180,000 | 0.05% |
CONNORS INVESTOR SERVICES INC | 3,591 | $216,000 | 0.05% |